Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | 7819995354 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36 Washington Street, Wellesley Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| Dofetilide D4；UK 68789 D4 | C19H27N3O5S2 | 1189700-56-8 | Details |
| Dopamine D2 receptor antagonist-1 | C14H17N3S | 1055411-77-2 | Details |
| Deschloroclozapine | C18H20N4 | 1977-07-7 | Details |
| Donitriptan | C23H25N5O2 | 170912-52-4 | Details |
| DOV-216,303 Free Base | C11H11Cl2N | 66504-40-3 | Details |
| DOTAP chloride | C42H80ClNO4 | 132172-61-3 | Details |
| NMI 8739 | C30H41NO3 | 129024-87-9 | Details |
| Doxepin D3 Hydrochloride | C19H19ClD3NO | 347840-07-7 | Details |
| MC-DOXHZN；Doxorubicin(6-maleimidocaproyl)hydrazone | C37H42N4O13 | 151038-96-9 | Details |
| Aldoxorubicin；DOXO-EMCH;INNO-206 | C37H42N4O13 | 1361644-26-9 | Details |
| Doxylamine D5 succinate | C21H28N2O5 | 1216840-94-6 | Details |
| DPBQ | C24H14N2O2 | 7029-89-2 | Details |
| (Z)-Capsaicin | C18H27NO3 | 25775-90-0 | Details |
| Dot1L-IN-2 | C27H24N8O | 1940206-71-2 | Details |
| DUB-IN-1 | C20H11N5O | 924296-18-4 | Details |
| DUB-IN-2 | C15H9N5O | 924296-19-5 | Details |
| Pralidoxime Chloride | C7H9ClN2O | 51-15-0 | Details |
| DS88790512 | C22H29N3O2 | 2231089-95-3 | Details |
| DS21360717 | C21H23N7O | 2304654-43-9 | Details |
| Meclizine dihydrochloride | C25H29Cl3N2 | 1104-22-9 | Details |
| DS-1040 Tosylate | C23H35N3O5S | 1335138-89-0 | Details |
| Drobuline hydrochloride | C19H26ClNO | 68162-52-7 | Details |
| Ciclopirox olamine | C14H24N2O3 | 41621-49-2 | Details |
| DW14800 | C31H36N4O3 | 2243709-60-4 | Details |
| DVD-445 | C25H28F2N2O4 | 2375846-41-4 | Details |
| Imazalil | C14H14Cl2N2O | 35554-44-0 | Details |
| Duocarmycin MA | C34H31ClN4O5 | 1613286-57-9 | Details |
| Dutogliptin tartrate；PHX-1149 | C14H26BN3O9 | 890402-81-0 | Details |
| EACC | C13H11N3O6S2 | 864941-31-1 | Details |
| EB-47 | C24H27N9O6 | 366454-36-6 | Details |
| EC5026 | C18H23F4N3O3 | 1809885-32-2 | Details |
| Duloxetine D3 hydrochloride；LY248686 D3 hydrochloride;(S)-Duloxetine D3 hydrochloride | C18H20ClNOS | 1435727-97-1 | Details |
| EC0488 | C65H98N16O34S | 1059477-92-7 | Details |
| EC1454 | C65H98N16O34S | 1602487-15-9 | Details |
| EC359 | C36H38F2O2 | 2012591-09-0 | Details |
| Duoperone | C28H26F4N2OS | 62030-88-0 | Details |
| Durlobactam sodium salt | C8H12N3NaO6S | 1467157-21-6 | Details |
| DUPA(OtBu)-OH | C23H40N2O9 | 1026987-94-9 | Details |
| DZ2002 | C10H13N5O3 | 33231-14-0 | Details |
| E-7386 | C39H48FN9O4 | 1799824-08-0 | Details |
| (E)-GABAB receptor antagonist 1 | C18H24O4 | 1611483-29-4 | Details |
| LHF-535 | C27H28N2O2 | 1450929-77-7 | Details |
| (E/Z)-BCI | C22H23NO | 15982-84-0 | Details |
| (E)-10-Hydroxynortriptyline maleate；(E)-10-Hydroxy Nortriptyline maleate | C23H25NO5 | 74853-74-0 | Details |
| DRI-C21045 | C32H24N2O7S | 2101765-81-3 | Details |
| DREADD agonist 21 | C17H18N4 | 56296-18-5 | Details |
| Durvalumab | 1428935-60-7 | Details |
| DPPH | C18H12N5O6* | 1898-66-4 | Details |
| DRAK2-IN-1 | C21H20N4O3 | 871837-60-4 | Details |
| EG00229 | C19H20F3N7O7S3 | 1210945-69-9 | Details |
| Edaravone-d5；MCI-186 D5;Edaravone D5 | C10H10N2O | 1228765-67-0 | Details |
| Ecteinascidin-Analog-1 | C31H44N2O9 | 874758-58-4 | Details |
| Ecteinascidin 770；Et-770;Ecteinascidine 770 | C40H42N4O10S | 114899-80-8 | Details |
| Doxylamine succinate | C21H28N2O5 | 562-10-7 | Details |
| Ecopladib | C39H33Cl3N2O5S | 381683-92-7 | Details |
| DYRKs-IN-1 | C30H30ClN7O4 | 1387090-01-8 | Details |
| DYRKs-IN-2 | C32H38ClN9O3 | 1386980-04-6 | Details |
| Duocarmycin SA | C25H23N3O7 | 130288-24-3 | Details |
| Duocarmycin TM | C25H23ClN2O5 | 157922-77-5 | Details |
| Duramycin；Moli1901;Lancovutide | C89H125N23O25S3 | 1391-36-2 | Details |
| Dutogliptin；PHX-1149 free base | C10H20BN3O3 | 852329-66-9 | Details |
| Duvelisib (R enantiomer)；INK1197 R enantiomer;Duvelisib R enantiomer;IPI-145 R enantiomer | C22H17ClN6O | 1261590-48-0 | Details |
| DSR-6434 | C19H28N8O2 | 1059070-10-8 | Details |
| Duocarmycin DM free base；Duocarmycin | C26H26ClN3O3 | 1116745-06-2 | Details |
| Duocarmycin MB | C27H26ClN3O4 | 1613286-58-0 | Details |
| Droloxifene | C26H29NO2 | 82413-20-5 | Details |
| DSP-0565 | C14H12FNO | 1226855-28-2 | Details |
| DSP-1053 | C26H32BrNO4 | 1176326-76-3 | Details |
| Droxicainide | C16H24N2O2 | 78289-26-6 | Details |
| E6130 | C28H37ClF3N3O3 | 1427058-33-0 | Details |
| E64FC26 | C19H23F3O2 | 2285446-62-8 | Details |
| 2-(Hydroxymethyl)pyridine | C6H7NO | 586-98-1 | Details |
| DuP 105 | C13H16N2O4S | 96800-41-8 | Details |
| DUB-IN-3 | C16H9N5O | 924296-17-3 | Details |
| Duloxetine metabolite Para-Naphthol Duloxetine；Para-Naphthol duloxetine | C18H19NOS | 949095-98-1 | Details |
| Duocarmycin GA | C26H25ClN4O3 | 1613286-59-1 | Details |
| DU717 | C12H15ClN4O2S | 59943-31-6 | Details |
| Dooku1 | C13H9Cl2N3OS | 2253744-54-4 | Details |
| Nithiamide | C5H5N3O3S | 140-40-9 | Details |
| Dot1L-IN-1 | C32H36ClN9O2S | 2088518-50-5 | Details |
| Dofetilide N-oxide；UK-116856 | C19H27N3O6S2 | 144449-71-8 | Details |
| Dolutegravir intermediate-1 | C13H17NO8 | 1335210-23-5 | Details |
| DS18561882 | C28H31F3N4O6S | 2227149-22-4 | Details |
| DS08210767 | C31H39N5O2 | 2376334-75-5 | Details |
| Ecastolol | C26H33N3O6 | 77695-52-4 | Details |
| EG01377 | C26H30N6O6S2 | 2227996-00-9 | Details |
| Nazartinib S-enantiomer；EGF816 (S-enantiomer) | C26H31ClN6O2 | 1508256-20-9 | Details |
| EGFR-IN-7 | C32H41BrN9O2P | 2267329-76-8 | Details |
| EGFR-IN-5 | C31H38FN9O | 2225887-26-1 | Details |
| EGFR-IN-8 | C32H23ClF3N7O4 | 2407957-87-1 | Details |
| EGFR-IN-9 | C29H24N4O3 | 1226549-39-8 | Details |
| Nazartinib mesylate；EGF816 (mesylate) | C27H35ClN6O5S | 1508250-72-3 | Details |
| EGFR-IN-1 | C28H30N6O4 | 1625677-63-5 | Details |
| EGFR-IN-2 | C26H33N9O3S | 1643497-70-4 | Details |
| Biotin | C10H16N2O3S | 58-85-5 | Details |
| EGFR-IN-1 hydrochloride | C28H31ClN6O4 | 2227455-78-7 | Details |
| EHMT2-IN-1 | C18H23N7O | 2230849-55-3 | Details |
| Eg5 Inhibitor V, trans-24 | C26H21N3O3 | 869304-55-2 | Details |
| EGLU | C7H13NO4 | 170984-72-2 | Details |
| Dopropidil | C20H35NO2 | 79700-61-1 | Details |
| Product Total： Product Page： | ||||
| 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 | ||||